Technology, particularly artificial intelligence (AI), represents the biggest structural shift in oncology drug development over the past 5 years, according to David Spigel, MD, p ...
Employers need a voice at the table with health systems, hospitals, and carriers in shaping cancer care, according to Rosa ...
Baricitinib is now FDA approved for adolescents 12 and older with severe alopecia areata, extending the once-daily pill ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results